Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Korea, republic of
  4. Korea Stock Exchange
  5. Cosmax Nbt, Inc.
  6. Summary
    A222040   KR7222040008

COSMAX NBT, INC.

(A222040)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Korea Stock Exchange
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
5550 5500 5380 5420 5340 Last
55527 34896 23339 36811 68870 Volume
+0.73% -0.90% -2.18% +0.74% -1.48% Change
Estimated financial data (e)
Sales 2021 310 B 0,26 B 0,26 B
Net income 2021 -1,00 B 0,00 B 0,00 B
Net Debt 2021 138 B 0,12 B 0,12 B
P/E ratio 2021 -80,9x
Yield 2021 -
Sales 2022 351 B 0,29 B 0,29 B
Net income 2022 11,0 B 0,01 B 0,01 B
Net Debt 2022 125 B 0,10 B 0,10 B
P/E ratio 2022 9,91x
Yield 2022 -
Capitalization 107 B 90,2 M 89,8 M
EV / Sales 2021 0,79x
EV / Sales 2022 0,66x
Nbr of Employees 579
Free-Float 61,0%
More Financials
Company
COSMAX NBT, INC., formerly NUTRIBIOTECH. CO., LTD., is a company mainly engaged in the manufacturing and sale of health functional foods. The Company is engaged in the research and development of functional raw materials and ingredients, the production and sale of health functional foods and health oriented foods. 
Sector
Food Processing
Calendar
04/01Earnings Release
More about the company
Ratings of Cosmax Nbt, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about COSMAX NBT, INC.
2019Nutribiotech Australia Pty. Ltd. announced that it has received AUD 10 million in fundi..
CI
2019Cosmax NBT announced that it has received KRW 10.5822 billion in funding from Cosmax Nb..
CI
2017NutriBiotech Co., Ltd. cancelled the acquisition of Nutribiotech Australia Pty. Ltd.
CI
More news
News in other languages on COSMAX NBT, INC.

- No features available -

More news
Chart COSMAX NBT, INC.
Duration : Period :
Cosmax Nbt, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 5 340,00 KRW
Average target price 14 000,00 KRW
Spread / Average Target 162%
EPS Revisions
Managers and Directors
Won-Il Yoon Chief Executive Officer & Director
Man-Seok Youn Senior Managing Director, Head-R&D
Tae-Young Jang Independent Director
Yeon-Hong Noh Independent Director
Byung-Joo Lee Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
COSMAX NBT, INC.-7.61%92
BY-HEALTH CO., LTD.-2.78%7 030
BALCHEM CORPORATION-11.85%4 813
HERBALIFE NUTRITION LTD.8.38%4 531
THE SIMPLY GOOD FOODS COMPANY-14.77%3 577
MEDIFAST, INC.-8.31%2 223